Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Gap26 in 3D Osteocyte Calcium Signaling
2026-08-18
Gap26 is a connexin 43 mimetic peptide for testing how mechanical stimuli become intercellular calcium signals. This article connects Gap26 perturbation with a 3D osteocyte microfluidic model, emphasizing causal assay design rather than a conventional product overview.
-
Probenecid: MRP Inhibition and Neuroprotection
2026-08-18
Probenecid, also known as 4-(dipropylsulfamoyl)benzoic acid, is a multitarget research inhibitor of organic anion transporters, MRPs, and pannexin-1 channels. Evidence supports its use as a transporter-focused chemosensitizer and as a mechanistic probe in cerebral ischemia/reperfusion models, while its selectivity and translational limits require careful controls.
-
Drug Response Metrics in Cancer Cell Assays
2026-08-17
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing why growth inhibition and cell killing should not be treated as interchangeable drug-response endpoints. Its framework supports more precise dose–time interpretation and helps researchers identify whether an apparent anticancer effect reflects proliferative arrest, death, or both.
-
Rotigotine in Parkinson’s Disease Research
2026-08-17
Rotigotine combines high-affinity D2/D3 receptor activation with a translationally relevant continuous-delivery concept for Parkinson’s disease and restless legs syndrome research. This guide converts that pharmacology into practical cell-based, oxidative-stress, and in vivo workflows, with dosing examples and troubleshooting strategies.
-
SIRT1, Mitochondrial Biogenesis, and Prion Toxicity
2026-08-16
Zhao and colleagues identify a SIRT1-dependent PGC-1α–TFAM pathway that links mitochondrial biogenesis to protection from PrP106–126-induced injury in N2a cells. The study positions resveratrol as a pharmacological SIRT1 activator for testing this mechanism, while also defining the limits of translating a peptide-based neuroblastoma model to prion disease biology.
-
Gap26: From Cx43 Channels to Translation
2026-08-15
Gap26, a connexin 43 mimetic peptide, gives translational researchers a practical way to test whether Cx43-mediated intercellular communication contributes to inflammatory, vascular, and neurobiological phenotypes.
-
Lisinopril Dihydrate: A Translational ACE Benchmark
2026-08-14
Lisinopril dihydrate is more than a familiar blood-pressure tool: it is a mechanistically anchored probe for renin–angiotensin system biology. This article connects ACE engagement, aminopeptidase selectivity, experimental design, and translational strategy across hypertension, heart failure, myocardial injury, and renal disease models.
-
Dantrolene Sodium Salt and CRISPR Repair Assays
2026-08-14
Dantrolene sodium salt is examined here as a calcium-channel perturbation tool for interpreting CRISPR DNA-repair screens, with practical guidance for separating RyR biology, cell survival, and editing outcomes.
-
mCherry mRNA for Robust Fluorescent Assays
2026-08-13
EZ Cap™ mCherry mRNA combines Cap 1, 5mCTP, ψUTP, and an approximately 100-nucleotide poly(A) tail for dependable transient fluorescent protein expression. This guide translates those design features into practical transfection, imaging, normalization, and troubleshooting workflows, while showing how the reporter can support delivery studies inspired by recent LNP-based gene-editing research.
-
Degarelix Acetate for Prostate Cancer: Evidence Review
2026-08-13
The 2009 review by Laurence Klotz presents degarelix acetate as a third-generation GnRH antagonist that achieves rapid medical castration without the testosterone surge associated with GnRH agonists. Its clinical importance lies in linking mechanism with trial evidence on testosterone suppression, prostate-specific antigen response, and safety in advanced prostate cancer.
-
L-NMMA Acetate in NO Pathway Research
2026-08-12
L-NMMA acetate enables a practical loss-of-function test for nitric oxide signaling in osteogenic, inflammatory, and pharmacological assays. This guide translates dental follicle cell findings into controlled workflows, dose-finding strategies, and troubleshooting decisions for reproducible NOS pathway modulation.
-
Dihydroethidium Workflow for Skin-Aging ROS Assays
2026-08-12
Learn how to use Dihydroethidium (DHE) as a live-cell superoxide readout in fibroblast models of D-galactose- and UVB-induced skin aging. This practical workflow emphasizes controls, imaging parameters, storage, and interpretation so oxidative stress assay results can be connected to senescence and MAPK biology without overstating what the probe measures.
-
Data-Driven Design of Small-Molecule Libraries
2026-08-11
Moret et al. introduce a data-driven framework for comparing and designing focused small-molecule collections using target coverage, binding selectivity, cellular phenotypes, chemical structure, clinical development status, and user preferences. Their optimized kinase and mechanism-of-action libraries show how computational selection can improve coverage while reducing redundant off-target overlap.
-
DAT PET Tracks Dopaminergic Neuron Maturation in PD
2026-08-11
Goggi et al. showed that serial dopamine transporter PET can assess the survival, maturation, and presynaptic integration of transplanted human embryonic stem cell-derived dopaminergic neurons in a rat model of Parkinson’s disease. The study also demonstrates why DAT imaging should be interpreted alongside functional imaging, behavioral testing, and endpoint histology rather than treated as a standalone measure of graft quality.
-
Malate Workflows for Tumor Immunometabolism
2026-08-10
Use malate as a controllable metabolic perturbation to connect mitochondrial redox, TCA-cycle flux, and macrophage function. This workflow-oriented guide shows how to pair (S)-2-hydroxysuccinic acid with biochemical, cellular, mitochondrial, and metabolomics readouts while avoiding common pH, viability, and normalization artifacts.